United States · 
What does Delaware Crossing Investor invest in?
Delaware Crossing Investor invests most often at Series A and Seed (75% of the rounds on record), in sectors such as Coupons, E-Commerce and Venture Capital & Private Equity.
Delaware Crossing Investor highlights
- 01
8 rounds on record
- 02
Mostly Series A and Seed: 75% of its rounds
- 03
2 exits from the portfolio
What they do
- Type
- Angel network (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries B
- Sectors
- CouponsE-CommerceVenture Capital & Private Equity
- Based in
- Warrington, United States
- Cold pitches
- Accepted
The record
Every round we can evidence, newest first8 appearances
- 2021
1 round
- Aug
- 2015
1 round
- May
- 2013
2 rounds
- May
- Mar
- 2012
1 round
- Aug
- 2011
2 rounds
- Jul
- Mar
- 2008
1 round
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
What they claim to have backed
From their own portfolio page (on their website)
2 of 10 we have independently watched raise
Honeycomb CreditMeasure StudioAcademy OneContact DesignersLuxtexhOral BiolifeSeneca TherapeuticSunray ScientificTrace OrthopedicsVytala
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
Novira TherapeuticsBought by Johnson & JohnsonUndisclosedNov 2015
Compliance AssuranceBought by StoneRiverUndisclosedNov 2012
An exit counts when it came after the firm's first round in the company. From historical deal records.